A Study of Elpipodect (MK-8189) in Participants With Bipolar I Disorder (MK-8189-020)

Clinical trial NCT06273774 · COMPLETED

Trial details

NCT number: NCT06273774
Sponsor: Merck Sharp & Dohme LLC
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Bipolar I Disorder

Start date: 2024-04-08
Primary completion: 2024-08-21
Enrollment: 34

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.